Search

ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

RESEARCH Editor | Curator -
Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.
View Post

Incredible Ibogaine Psychedelic’s Testimonial.

TESTIMONIALS Editor | Curator -
TIME MAGAZINE: Marcus Capone, Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction
View Post

America’s Top Doc Bankole Johnson Joins Ehave’s (EHVVF) Medical Advisory Board.

PSYCH STOCK NEWS Editor | Curator -
Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave...
View Post

Psychedelic IPOs Build Momentum (PitchBook).

PSYCH STOCK NEWS Editor | Curator -
Psychedelic IPOs build momentum as Atai Life Sciences goes public PITCHBOOK Making its Wall Street debut,...
View Post

Psychedelic Investor Conferences.

CONFERENCES Editor | Curator -
Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 – But Worth Considering!
View Post

Biomind Labs Inc. Completes Reverse Take-Over Transaction

PSYCH STOCK NEWS Editor | Curator -
TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (formerly Crosswinds Holdings Inc.) (the “Company”), announces that it has completed its previously announced acquisition of all of...
View Post

10 Psychedelic Startups Investors are Flocking To (Insider Monkey)

PSYCH STOCK NEWS Editor | Curator -
In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of...
View Post

Revive Therapeutics (RVV:CN, RVVTF) Approved to Trade on the OTCQB Market.

PSYCH STOCK NEWS Editor | Curator -
TORONTO, June 25, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences...
View Post

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

TESTIMONIALS Editor | Curator -
Therapy Treatment Performed by Ehave’s (EHVVF) Chief Medical Office Dr. Jeffrey Kamlet Received Rave Reviews and Offers the Potential to Save Lives.
View Post

Cybin (CYBN) Enters into Collaboration Agreement with Greenbrook TMS (GBNH) to Establish Mental Health Centers of Excellence.

PSYCH STOCK NEWS Editor | Curator -
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin” or the “Company”), a biotechnology company focused on progressing psychedelic therapeutics, today...
View Post

How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham (Stockhead)

INTERVIEW Editor | Curator -
Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy development – and they’re looking at an excursion to...
View Post

Interview: Matt Stang, CEO of Delic (DELCF). Wall Street Reporter

CLINICS Editor | Curator -
#delcf, #DELIC $delcf
View Post

Protected: Private Post

Uncategorized Editor | Curator -
Password Please
View Post
1...91011Page 10 of 11

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Interview: MAPS Founder Rick Doblin and Clearmind Medicine (CMND) CEO, Adi Zuloff-Shani.

2024 WATCH LIST Editor | Curator -
INTRO VIDEO https://youtu.be/-RQikn6O3qw?si=o_IBy9yTlmfNNvky Join Clearmind Medicine CEO, Adi Zuloff-Shani,...

1000 Days Without Alcohol: Here’s What Happened

ALCOHOL Editor | Curator -
No..we didn't give up drinking - at least not yet. But we RUMinate about it from time to time. At a dinner...

Startup Ketamine Clinic ‘Being Health’ Raises $5.4 Million

CLINICS Editor | Curator -
This startup is opening a mental health clinic that offers ketamine therapy. BusinessInsider got an exclusive look at the pitch deck it...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS

Copyright Revelers,io Media for Instiutional Analyst Inc.